Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISOCABTAGENE MARALEUCEL for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where LISOCABTAGENE MARALEUCEL was used for Lymphoma.

Most Reported Side Effects for LISOCABTAGENE MARALEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 315 42.7% 48 189
Immune effector cell-associated neurotoxicity syndrome 129 17.5% 22 74
Neurotoxicity 101 13.7% 7 68
Pyrexia 47 6.4% 3 37
Fatigue 38 5.2% 2 9
Hypotension 38 5.2% 8 26
Febrile neutropenia 28 3.8% 2 26
Confusional state 27 3.7% 1 22
Death 25 3.4% 25 5
Lymphocyte adoptive therapy 25 3.4% 4 19
Malignant neoplasm progression 23 3.1% 13 10
Platelet count decreased 23 3.1% 8 5
Tremor 22 3.0% 1 13
Aphasia 21 2.9% 1 16
Neutropenia 21 2.9% 5 11

Other Indications for LISOCABTAGENE MARALEUCEL

Diffuse large b-cell lymphoma (347) B-cell lymphoma (57) Product used for unknown indication (56) Chronic lymphocytic leukaemia (47) Follicular lymphoma (38) Mantle cell lymphoma (25) Diffuse large b-cell lymphoma refractory (21) Diffuse large b-cell lymphoma recurrent (16) Non-hodgkin's lymphoma (15) Marginal zone lymphoma (10)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

LISOCABTAGENE MARALEUCEL Full Profile All Lymphoma Drugs LISOCABTAGENE MARALEUCEL Demographics LISOCABTAGENE MARALEUCEL Timeline